Brief: Kronos Bio Reports Recent Business Progress And Second-Quarter 2022 Financial Results
04/08/2022 22:50
Aug 4 (Reuters) - Kronos Bio Inc KRON.O :
* KRONOS BIO REPORTS RECENT BUSINESS PROGRESS AND
SECOND-QUARTER
2022 FINANCIAL RESULTS
* KRONOS BIO INC - $292.4 MILLION IN CASH, CASH EQUIVALENTS
AND
INVESTMENTS AS OF JUNE 30, 2022, PROVIDING EXPECTED CASH RUNWAY
INTO Q4 2024
* KRONOS BIO INC - QTRLY LOSS PER SHARE $0.59
Source text for Eikon: ID:nGNX60BG9Z
Further company coverage: KRON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kronos Bio
See all newsBrief: Kronos Bio Inc - Terminates Office Lease At 301 Binney Street - SEC Filing
Brief: Kronos Bio Inc - Enters Transition Agreement With Genentech
U.S. STOCKS ON THE MOVE - Ambarella, Dell, Nordstrom
U.S. STOCKS ON THE MOVE - Golden Ocean, Guess, Symbotic
U.S. STOCKS ON THE MOVE-HP, Urban Outfitters, 3D Systems